Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

Share Price is delayed by 15 minutes
Get Live Data
65.00    0.00 (0.00%)
Bid:
64.00
Ask:
67.80
Spread: 3.80 (5.938%)
Market Cap: £111.74m
GABI Live PriceLast checked at - London Stock Exchange

Intraday Gcp Asset Bckd Share Chart

Result of Placing

8 Nov 2016 07:00

RNS Number : 5467O
GCP Asset Backed Income Fund Ltd
08 November 2016
 

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO US PERSONS OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR THE UNITED STATES OF AMERICA OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

8 November 2016

GCP Asset Backed Income Fund Ltd (the "Company")

Result of Placing

Further to the announcement by the Company on 2 November the Board is pleased to announce that 14,964,734 new ordinary shares will be issued at a price of 104.5 pence raising gross proceeds of approximately £15.6 million. The Board is pleased to announce that the Placing has been substantially oversubscribed.

The net proceeds of the Placing will be used to take advantage of attractive investment opportunities identified by the Investment Manager, Gravis Capital Partners LLP.

Applications have been made in respect of 14,964,734 new ordinary shares to be admitted to trading on the London Stock Exchange's Main Market for listed securities and to listing on the Premium Listing segment of the Official List of the UK Listing Authority ("Admission"). It is expected that Admission will become effective and dealings in the new ordinary shares will commence at 8.00 a.m. (London time) on 10 November.

The new ordinary shares will, when issued, rank pari passu in all respects with the existing ordinary shares, including in respect of the right to receive all future dividends and distributions declared, made or paid by reference to a record date falling after their issue. For the avoidance of doubt, subscribers for new ordinary shares pursuant to the Placing will not be entitled to the dividend of 1.5 pence per ordinary share in respect of the quarterly period ended 30 September 2016 announced on 19 October 2016 for which the record date was 28 October.

Following Admission, the Company's issued share capital will consist of 164,612,083 ordinary shares of no par value. With effect from 10 November 2016, the total number of issued shares with voting rights will be 164,612,083.

The above figure of 164,612,083 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or of a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules. 

This announcement contains Inside Information as defined under the Market Abuse Regulation (EU) No. 596/2014.

For further information, please contact:

 

Gravis Capital Partners LLP +44 (0)20 7518 1490

David Conlon

david.conlon@gcpuk.com

Philip Kent

 

Dion Di Miceli

philip.kent@gcpuk.com

 

dion.dimiceli@gcpuk.com

Cenkos Securities plc

+44 (0)20 7397 8900

Tom Scrivens

tscrivens@cenkos.com

Oliver Packard

opackard@cenkos.com

Sapna Shah

sshah@cenkos.com

Buchanan

+44 (0)20 7466 5000

Charles Ryland

charlesr@buchanan.uk.com

Vicky Watkins

victoriaw@buchanan.uk.com

 

Notes to Editors

The Company

The Company is a closed ended investment company traded on the Main Market of the London Stock Exchange. Its investment objective is to generate attractive risk-adjusted returns primarily through regular, growing distributions and modest capital appreciation over the long term.

The Company seeks to meet its investment objective by making investments in a diversified portfolio of predominantly UK based asset backed loans which have contracted, predictable medium to long term cash flows and/or physical assets.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIFMMGMRNGGVZM
Date   Source Headline
12th Jun 20264:22 pmRNSHolding(s) in Company
12th Jun 202612:32 pmRNSHolding(s) in Company
2nd Jun 20267:37 amRNSDisposal of care home loan portfolio
22nd May 202612:00 pmRNSResults of Annual General Meeting
29th Apr 20265:45 pmRNSDividend Declaration
15th Apr 20269:30 amRNSNotice of Annual General Meeting
31st Mar 20267:00 amRNSAnnual Report and Accounts
19th Feb 20267:00 amRNSInvestor report at 31 December 2025
2nd Feb 20267:00 amRNSRealisation Plan Update, NAV and Dividend
31st Dec 20257:00 amRNSTotal Voting Rights
10th Dec 20252:27 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNSThird Capital Distribution Update
26th Nov 20257:00 amRNSThird Compulsory Redemption & Dividend Declaration
11th Sep 20257:00 amRNSHalf-year Report
13th Aug 20257:00 amRNSInvestor report at 30 June 2025
24th Jul 20257:00 amRNSNet Asset Value and Dividend Declaration
20th Jun 20254:01 pmRNSHolding(s) in Company
6th Jun 202510:53 amRNSResults of Annual General Meeting
27th May 20252:05 pmRNSHolding(s) in Company
15th May 20254:30 pmRNSHolding(s) in Company
15th May 20254:28 pmRNSHolding(s) in Company
8th May 20259:30 amRNSNotice of Annual General Meeting
6th May 20251:10 pmRNSChange of Auditor
1st May 202510:21 amRNSDividend Declaration
30th Apr 20257:00 amRNSAnnual Report and Accounts
27th Feb 20257:00 amRNSInvestor report at 31 December 2024
12th Feb 20257:00 amRNSNet Asset Value and Dividend Declaration
4th Dec 20246:23 pmRNSHolding(s) in Company
29th Nov 20247:00 amRNSTotal Voting Rights
19th Nov 20241:33 pmRNSHolding(s) in Company
18th Nov 20247:00 amRNSSecond Capital Distribution Update
6th Nov 20246:20 pmRNSDividend & Second Compulsory Redemption
6th Nov 20247:00 amRNSDividend & Second Compulsory Redemption
18th Oct 20247:00 amRNSSecond Compulsory Redemption
19th Sep 20247:00 amRNSHalf-Yearly Report & Financial Statements
27th Aug 20247:00 amRNSInvestor report at 30 June 2024
30th Jul 20247:00 amRNSDividend Declaration
26th Jul 20247:00 amRNSQuarterly Update
23rd Jul 202410:56 amRNSDirector Declaration
8th Jul 20244:03 pmRNSLoan Repayment
4th Jul 20244:10 pmRNSPublication of Managed Realisation Plan
1st Jul 202412:23 pmRNSHolding(s) in Company
28th Jun 20247:00 amRNSTotal Voting Rights
11th Jun 20247:00 amRNSInitial Capital Distribution Update
7th Jun 20244:04 pmRNSCancellation of Shares held in Treasury
3rd Jun 20242:42 pmRNSLoan Repayment & Increased Return of Capital
30th May 20245:39 pmRNSDirector/PDMR Shareholding
29th May 20244:47 pmRNSForm 8.3 - GCP Asset Backed Income Fund Limited
29th May 20243:29 pmRNSForm 8.3 - GCP Asset Backed Income Fund Ltd
29th May 20242:01 pmRNSReturn of Capital & Conclusion of Strategic Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.